Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.38%502.15M | 17.96%432.61M | 15.49%407.02M | -1.84%1.65B | 1.63%463.13M | -4.41%467.63M | -4.79%366.73M | 0.50%352.41M | -23.17%1.68B | 1.12%455.68M |
| Cost of revenue | 7.86%363.07M | 13.92%329.84M | 12.55%305.94M | -1.71%1.25B | 2.68%350.74M | -6.15%336.63M | -3.37%289.54M | 0.41%271.82M | -13.92%1.27B | 13.10%341.6M |
| Gross profit | 6.16%139.08M | 33.13%102.77M | 25.42%101.08M | -2.22%400.98M | -1.48%112.39M | 0.37%131M | -9.75%77.2M | 0.83%80.6M | -42.36%410.08M | -23.23%114.09M |
| Operating expense | 21.10%46.51M | 6.25%35.23M | 16.98%36.52M | 25.74%182.15M | 9.28%54.97M | 9.33%38.41M | 7.50%33.16M | 9.75%31.22M | -31.97%144.86M | -28.14%50.3M |
| Selling and administrative expenses | 15.82%46.55M | 8.67%34.62M | 22.01%37.24M | 7.68%157.77M | 3.69%54.09M | 14.30%40.19M | 3.16%31.86M | 8.45%30.53M | -25.97%146.51M | 0.96%52.17M |
| -Selling and marketing expense | 3.03%31.48M | 11.20%25.36M | 37.90%27.42M | 14.49%106.3M | 19.51%32.97M | 17.85%30.56M | 14.07%22.81M | 2.86%19.88M | -33.25%92.84M | 8.66%27.59M |
| -General and administrative expense | 56.38%15.06M | 2.31%9.26M | -7.66%9.83M | -4.10%51.47M | -14.06%21.13M | 4.33%9.63M | -16.89%9.05M | 20.71%10.64M | -8.76%53.67M | -6.48%24.58M |
| Other operating expenses | -26.07%2.64M | -0.47%2.94M | -31.90%2.72M | 139.63%38.07M | -12.41%4.13M | -9.40%3.58M | -16.49%2.96M | 8.50%4M | -50.20%15.89M | -77.28%4.71M |
| Total other operating income | -50.03%2.68M | 40.66%2.34M | 4.35%3.45M | -21.97%13.68M | -50.57%3.25M | 34.67%5.36M | -53.66%1.66M | -2.39%3.31M | 3.85%17.53M | 170.84%6.58M |
| Operating profit | -0.03%92.57M | 53.36%67.54M | 30.76%64.57M | -17.49%218.83M | -9.97%57.43M | -2.93%92.6M | -19.48%44.04M | -4.10%49.38M | -46.80%265.22M | -18.87%63.79M |
| Net non-operating interest income (expenses) | 108.79%1.9M | 64.77%2.63M | -7.36%755K | 386.34%6.3M | 119.58%3.13M | 84.96%910K | 1,872.84%1.6M | 216.10%815K | 142.42%1.3M | 133.04%1.43M |
| Non-operating interest income | 44.62%3.17M | 18.69%3.65M | -23.40%1.86M | 10.60%12.02M | 20.71%4.37M | -8.81%2.19M | 12.92%3.08M | 14.55%2.43M | 34.17%10.87M | 15.67%3.62M |
| Non-operating interest expense | -0.86%1.27M | -31.10%1.02M | -31.48%1.11M | -40.27%5.72M | -43.59%1.24M | -32.92%1.28M | -44.06%1.48M | -42.76%1.62M | -14.19%9.57M | -12.87%2.19M |
| Net investment income | -4,232.41%-6.28M | -4,232.41%-6.28M | -145K | -145K | ||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -1.86%11.36M | 11.87%9.63M | 14.58%7.6M | 36.39%34.45M | -9.62%7.63M | 56.37%11.58M | 95.64%8.61M | 32.36%6.63M | -38.54%25.26M | 39.09%8.44M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 349.05%53.98M | -76.86%-21.67M | ||||||||
| Income before tax | 0.71%105.83M | 47.11%79.8M | 28.32%72.92M | 16.09%313.56M | -15.79%61.9M | 1.74%105.08M | -8.33%54.25M | 1.84%56.83M | -48.48%270.1M | 0.63%73.51M |
| Income tax | 8.98%25.69M | 56.41%21.57M | 42.72%20.31M | 20.67%82.42M | -8.32%18.63M | -2.49%23.57M | -14.01%13.79M | 9.71%14.23M | -47.18%68.3M | -26.38%20.32M |
| Net income | -2.00%91.87M | 14.06%68.86M | 4.05%53.06M | 14.54%231.14M | 29.56%26.45M | 11.58%93.74M | 12.13%60.37M | 17.16%51M | -48.91%201.8M | -36.23%20.42M |
| Net income continuous operations | -1.68%80.14M | 43.94%58.23M | 23.51%52.61M | 14.54%231.14M | -18.64%43.27M | 3.03%81.51M | -6.22%40.45M | -0.54%42.6M | -48.91%201.8M | 17.02%53.19M |
| Net income extraordinary | -4.12%11.72M | -46.64%10.63M | -94.63%451K | 244.02%23.72M | 48.68%-16.82M | 149.55%12.23M | 86.09%19.91M | 1,100.00%8.4M | ---16.47M | ---32.77M |
| Noncontrolling interests | -12.68%16.95M | 25.18%14.59M | 46.89%11.39M | 13.48%50.55M | -13.77%9.1M | 2.85%19.41M | 7.27%11.65M | 82.01%7.75M | -40.19%44.55M | 9.09%10.56M |
| Net income attributable to the company | 0.79%74.92M | 11.40%54.27M | -3.63%41.68M | 14.84%180.58M | 75.95%17.35M | 14.11%74.33M | 13.35%48.71M | 10.12%43.25M | -50.93%157.25M | -55.86%9.86M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 0.79%74.92M | 11.40%54.27M | -3.63%41.68M | 14.84%180.58M | 75.95%17.35M | 14.11%74.33M | 13.35%48.71M | 10.12%43.25M | -50.93%157.25M | -55.86%9.86M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.77%0.1701 | 11.39%0.1232 | -3.67%0.0946 | 14.85%0.41 | 75.89%0.0394 | 14.13%0.1688 | 13.32%0.1106 | 10.09%0.0982 | -50.93%0.357 | -55.82%0.0224 |
| Diluted earnings per share | 0.77%0.1701 | 11.39%0.1232 | -3.67%0.0946 | 14.85%0.41 | 75.89%0.0394 | 14.13%0.1688 | 13.32%0.1106 | 10.09%0.0982 | -50.93%0.357 | -55.82%0.0224 |
| Dividend per share | 0.1 | -33.33%0.1 | 0 | 40.00%0.35 | 33.33%0.2 | 0 | 50.00%0.15 | 0 | -37.50%0.25 | 50.00%0.15 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.